Cited 0 times in
A first-in-human, open-label, dose-escalation study to investigate the safety and tolerability of CHC2014, a tropomyosin receptor kinase (TRK) inhibitor, in adult patients with advanced solid tumors
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-06-02T00:37:24Z | - |
dc.date.available | 2023-06-02T00:37:24Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 0923-7534 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194314 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Oxford University Press | - |
dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | A first-in-human, open-label, dose-escalation study to investigate the safety and tolerability of CHC2014, a tropomyosin receptor kinase (TRK) inhibitor, in adult patients with advanced solid tumors | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | T. Yun | - |
dc.contributor.googleauthor | S.J. Shin | - |
dc.contributor.googleauthor | D-W. Kim | - |
dc.contributor.googleauthor | C.H. Yun | - |
dc.contributor.googleauthor | S. Heo | - |
dc.contributor.googleauthor | B. Hyun | - |
dc.contributor.googleauthor | Y.S. Kim | - |
dc.contributor.googleauthor | J.S. Kim | - |
dc.contributor.googleauthor | Y.W. Moon | - |
dc.identifier.doi | 10.1016/j.annonc.2022.01.053 | - |
dc.relation.journalcode | J00171 | - |
dc.identifier.eissn | 1569-8041 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S092375342200062X | - |
dc.citation.volume | 33 | - |
dc.citation.number | Suppl.1 | - |
dc.citation.startPage | S20 | - |
dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl.1) : S20, 2022-03 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.